ArticleJournal of experimental & clinical cancer research : CR2025

Sensitive detection of minimal residual disease and immunotherapy targets by multi-modal bone marrow analysis in high-risk neuroblastoma - a multi-center study.

Nina U Gelineau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.